(VIANEWS) – Amphastar Pharmaceuticals (AMPH), The Travelers Companies (TRV), Northeast Community Bancorp (NECB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Amphastar Pharmaceuticals (AMPH)
34% sales growth and 24.59% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.56.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 21.05. Meaning, the purchaser of the share is investing $21.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.59%.
Sales Growth
Amphastar Pharmaceuticals’s sales growth is 30.8% for the current quarter and 34% for the next.
2. The Travelers Companies (TRV)
10.6% sales growth and 10.95% return on equity
The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. It operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners' insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.
Earnings Per Share
As for profitability, The Travelers Companies has a trailing twelve months EPS of $12.79.
PE Ratio
The Travelers Companies has a trailing twelve months price to earnings ratio of 16.67. Meaning, the purchaser of the share is investing $16.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.95%.
Sales Growth
The Travelers Companies’s sales growth is 13.1% for the present quarter and 10.6% for the next.
Yearly Top and Bottom Value
The Travelers Companies’s stock is valued at $213.22 at 15:22 EST, under its 52-week high of $214.29 and way above its 52-week low of $157.33.
Moving Average
The Travelers Companies’s value is way higher than its 50-day moving average of $183.54 and way above its 200-day moving average of $173.67.
Previous days news about The Travelers Companies(TRV)
- According to Zacks on Monday, 29 January, "Some other top-ranked stocks from the same space are CNA Financial Corporation (CNA Quick QuoteCNA – Free Report) , The Progressive Corporation (PGR Quick QuotePGR – Free Report) and The Travelers Companies (TRV Quick QuoteTRV – Free Report) .CNA Financial delivered a trailing four-quarter average earnings surprise of 9.24%. "
3. Northeast Community Bancorp (NECB)
9% sales growth and 15.94% return on equity
Northeast Community Bancorp, Inc. operates as the holding company for Northeast Community Bank that provides various financial services to consumers and businesses. The company accepts deposit products, such as checking, money market, savings, and individual retirement accounts, as well as certificates of deposit. Its loan products include multi-family, mixed-use, and real estate loans; commercial and industrial loans; construction loans; consumer loans; passbook, term, small business administration, and cooperative building loans; and revolving lines of credit. The company also offers various ATM/debit, credit, and gift cards; and investment advisory and financial planning, direct and remote deposit, wire transfer, automated clearing house, credit card merchant, coin and currency, and cash management services, as well as Internet, mobile, and telephone banking services. It operates three full-service branches in New York; three full-service branches in Massachusetts; one full service branch in Rockland County; two full service branch offices in Orange County; and a loan production office in New City, New York. The company was founded in 1934 and is headquartered in White Plains, New York. Northeast Community Bancorp, Inc. is a subsidiary of Northeast Community Bancorp, MHC.
Earnings Per Share
As for profitability, Northeast Community Bancorp has a trailing twelve months EPS of $2.92.
PE Ratio
Northeast Community Bancorp has a trailing twelve months price to earnings ratio of 5.74. Meaning, the purchaser of the share is investing $5.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.94%.
Yearly Top and Bottom Value
Northeast Community Bancorp’s stock is valued at $16.75 at 15:22 EST, under its 52-week high of $17.95 and way higher than its 52-week low of $12.50.
Sales Growth
Northeast Community Bancorp’s sales growth is 22.3% for the ongoing quarter and 9% for the next.
Moving Average
Northeast Community Bancorp’s worth is below its 50-day moving average of $17.02 and way above its 200-day moving average of $15.21.
4. JinkoSolar Holding Company Limited (JKS)
7.2% sales growth and 24.23% return on equity
JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products. The company offers solar modules, silicon wafers, solar cells, recovered silicon materials, and silicon ingots. It also provides solar system integration services; and develops commercial solar power projects. The company sells its products to distributors, project developers, and system integrators; and utility, commercial, and residential customers under the JinkoSolar brand, as well as on an original equipment manufacturer basis. As of December 31, 2019, it had an integrated annual capacity of 15.0 gigawatt (GW) for silicon wafers, including 11.5 GW for mono wafers; 10.6 GW for solar cells; and 16.0 GW for solar modules. The company has operations in the People's Republic of China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and internationally. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.
Earnings Per Share
As for profitability, JinkoSolar Holding Company Limited has a trailing twelve months EPS of $10.24.
PE Ratio
JinkoSolar Holding Company Limited has a trailing twelve months price to earnings ratio of 2.86. Meaning, the purchaser of the share is investing $2.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.23%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 193.9% and a drop 36.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
JinkoSolar Holding Company Limited’s EBITDA is 2.52.
Sales Growth
JinkoSolar Holding Company Limited’s sales growth is negative 5.1% for the present quarter and 7.2% for the next.
Moving Average
JinkoSolar Holding Company Limited’s worth is way below its 50-day moving average of $32.99 and way below its 200-day moving average of $36.99.
